ArticleJournal of applied clinical medical physics2018
Institutional experience with SRS VMAT planning for multiple cranial metastases.
Article in Journal of applied clinical medical physics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 51 citations in OpenAlex.
- Automatic single-isocenter multiple-target cranial stereotactic treatment plan optimization via planning system scripting.Journal of applied clinical medical physics · 2026Article
- Benchmarking intermediate dose spillage in single target stereotactic radiosurgery for brain metastases.Physics and imaging in radiation oncology · 2026Article
- Article
- Dosimetric optimization for dynamic mixed beam arc therapy (DYMBARC).Medical physics · 2025Article
- AFI manual planning versus HyperArc auto-planning: A head-to-head comparison of SRS plan quality.Journal of applied clinical medical physics · 2024Article
- Letter to the Editor: reply to "Comparison of patient setup accuracy for optical surface-guided and X-ray-guided imaging with respect to the impact on intracranial stereotactic radiotherapy".Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024Article
- AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QA.Medical physics · 2023Review
- Automatically tracking brain metastases after stereotactic radiosurgery.Physics and imaging in radiation oncology · 2023Article
- Planning issues on linac-based stereotactic radiotherapy.World journal of clinical cases · 2022Review
- Single isocenter stereotactic irradiation for multiple brain metastases: current situation and prospects.Japanese journal of radiology · 2022Review
- Portal dosimetry correction method for validation of single isocenter VMAT plans for multiple brain metastases.Journal of applied clinical medical physics · 2022Article
- Impact of systematic MLC positional uncertainties on the quality of single-isocenter multi-target VMAT-SRS treatment plans.Journal of applied clinical medical physics · 2022Article
- Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems.Radiation oncology (London, England) · 2022Article
- How to estimate R50% for cranial SRS/SRT cases with overlapping 50% isodose volumes: A proposed system.Journal of applied clinical medical physics · 2022Article
- A measure of SRS/SRT plan quality: Quantitative limits for intermediate dose spill (R50%) in linac-based delivery.Journal of applied clinical medical physics · 2022Article
- Automatic segmentation of brain metastases using T1 magnetic resonance and computed tomography images.Physics in medicine and biology · 2021Article
- Investigating the impacts of intrafraction motion on dosimetric outcomes when treating small targets with virtual cones.Journal of applied clinical medical physics · 2021Article
- Single isocenter SRS using CAVMAT offers improved robustness to commissioning and treatment delivery uncertainty compared to VMAT.Journal of applied clinical medical physics · 2021Article
- Dosimetric comparison of multiple vs single isocenter technique for linear accelerator-based stereotactic radiosurgery: The Importance of the six degree couch.Journal of applied clinical medical physics · 2021Article
- Efficient optimization of R50% when planning multiple cranial metastases simultaneously in single isocenter SRS/SRT.Journal of applied clinical medical physics · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
background and purposeThis study summarizes the cranial stereotactic radiosurgery (SRS) volumetric modulated arc therapy (VMAT) procedure at our institution. MATERIALS AND
methodsVolumetric modulated arc therapy plans were generated for 40 patients with 188 lesions (range 2-8, median 5) in Eclipse and treated on a TrueBeam STx. Limitations of the custom beam model outside the central 2.5 mm leaves necessitated more than one isocenter pending the spatial distribution of lesions. Two to nine arcs were used per isocenter. Conformity index (CI), gradient index (GI) and target dose heterogeneity index (HI) were determined for each lesion. Dose to critical structures and treatment times are reported.
resultsLesion size ranged 0.05-17.74 cm
conclusionsVolumetric modulated arc therapy provide plans with steep dose gradients around the targets and low dose to critical structures, and VMAT treatment is delivered in a shorter time than conventional methods using one isocenter per lesion. To further improve VMAT planning for multiple cranial metastases, better tools to shorten planning time are needed. The most significant improvement would come from better dose modeling in Eclipse, possibly by allowing for customizing the dynamic leaf gap (DLG) for a special SRS model and not limit to one DLG per energy per treatment machine and thereby remove the limitation on the Y-jaw and allow planning with a single isocenter.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.